title: Behçet disease: advantageous against development of neoplasia?
authors.forename: I
authors.initials: I
authors.lastname: Celík
authors.forename: I
authors.initials: I
authors.lastname: Barişta
authors.forename: G
authors.initials: G
authors.lastname: Tekuzman
authors.forename: E
authors.initials: E
authors.lastname: Kansu
authors.forename: S
authors.initials: S
authors.lastname: Kíraz
authors.forename: M
authors.initials: M
authors.lastname: Calgünerí
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001528:Behcet Syndrome / Q000276:immunology*; D005260:Female; D015235:HLA-B Antigens; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology
chemical_list: D015235:HLA-B Antigens; C035270:HLA-B5 antigen